Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance

被引:6
|
作者
Kim, Seon Young [1 ,2 ]
Im, Kyongok [3 ]
Park, Si Nae [3 ]
Kim, Jung-Ah [1 ]
Yoon, Sung-Soo [3 ,4 ]
Lee, Dong Soon [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Lab Med, 101 Daehak Ro, Seoul 110744, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Lab Med, Daejeon, South Korea
[3] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
基金
新加坡国家研究基金会;
关键词
AL amyloidosis; Monoclonal gammopathy of undermined significance; Multiple myeloma; Cytogenetics; IN-SITU HYBRIDIZATION; HIGH-DOSE MELPHALAN; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; AL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; GENETIC EVENTS; TRANSPLANTATION; TRANSLOCATIONS;
D O I
10.1016/j.leukres.2016.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We performed cytoplasmic fluorescence in situ hybridization assays of light chain amyloidosis (AL). In total, 234 patients were enrolled: 28 patients with AL, 24 with monoclonal gammopathy of undetermined significance (MGUS), and 182 with multiple myeloma (MM). Chromosomal abnormalities were detected in 13 of 22 (59%) AL patients without MM. All 13 patients demonstrated IGH rearrangement, and t(11;14)1IGH-CCND1 was most frequent (32%). Chromosome gain was not observed in AL patients without MM. These findings were dissimilar to findings in MGUS patients, in whom trisomy 9 was the most frequent abnormality. Of 6 AL patients with MM, 5 (83%) patients had cytogenetic abnormalities: lq gain (4/6, 67%), gains of chromosome 9 (3/6, 50%), IGH rearrangement and RBI (13q) deletions (2/6 each, 33%). The percentage of clonal plasma cells among total plasma cells was variable (median, 75%; range, 16-100%) for AL patients without MM, which was lower than the results for MM patients (median 100%). The overall survival of AL patients without MM was not significantly different according to the presence of cytogenetic abnormalities (13= 0.510). In summary, among Korean AL patients, IGH rearrangement was the most frequent cytogenetic abnormality and cytogenetic aberration patterns differ compared with MGUS and MM patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [41] Bone Marrow Plasma Cell Infiltration in Light-Chain Amyloidosis
    Gerardo Rodriguez-Lobato, Luis
    Tovar, Natalia
    Teresa Cibeira, Ma
    Magnano, Laura
    Isola, Ignacio
    Rosinol, Laura
    Blade, Joan
    Fernandez de Larrea, Carlos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S236 - S236
  • [42] Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
    Dohy, Zsofia
    Szabo, Liliana
    Pozsonyi, Zoltan
    Csecs, Ibolya
    Toth, Attila
    Suhai, Ferenc Imre
    Czimbalmos, Csilla
    Szucs, Andrea
    Kiss, Anna Reka
    Becker, David
    Merkely, Bela
    Vago, Hajnalka
    PLOS ONE, 2022, 17 (06):
  • [43] The effect of membranes and surfaces on the fibrillation of an amyloidogenic light chain: Relevance to the etiology of AL amyloidosis
    Meng, X.
    Zhu, M.
    Fink, A. L.
    XIth International Symposium on Amyloidosis, 2008, : 3 - 6
  • [44] Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
    Kumar, Shaji
    Dispenzieri, Angela
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Colby, Colin
    Laumann, Kristina
    Zeldenrust, Steve R.
    Leung, Nelson
    Dingli, David
    Greipp, Philip R.
    Lust, John A.
    Russell, Stephen J.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) : 989 - 995
  • [45] Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome
    Milani, Paolo
    Basset, Marco
    Russo, Francesca
    Foli, Andrea
    Merlini, Giampaolo
    Palladini, Giovanni
    BLOOD, 2017, 130 (05) : 625 - 631
  • [46] PROGNOSTIC SIGNIFICANCE OF CLONAL CIRCULATING PLASMA CELLS BY MULTI-PARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
    Sidana, S.
    Tandon, N.
    Dispenzieri, A.
    Gertz, M. A.
    Buadi, F. K.
    Lacy, M. Q.
    Dingli, D.
    Fonder, A. L.
    Hayman, S. R.
    Hobbs, M. A.
    Hwa, Y. L.
    Kapoor, P.
    Kyle, R. A.
    Leung, N.
    Go, R. S.
    Lust, J. A.
    Russell, S. J.
    Rajkumar, S. V.
    Kumar, S. K.
    Gonsalves, W. I.
    HAEMATOLOGICA, 2017, 102 : 267 - 268
  • [47] Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis
    Lisenko, Katharina
    Schoenland, Stefan O.
    Jauch, Anna
    Andrulis, Mindaugas
    Roecken, Christoph
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hegenbart, Ute
    Hundemer, Michael
    CANCER MEDICINE, 2016, 5 (07): : 1464 - 1472
  • [48] Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells
    Zhang, Cong-li
    Qiu, Yu
    Shen, Kai-ni
    Miao, Hui-lei
    Feng, Jun
    Cao, Xin-xin
    Zhang, Lu
    Jiang, Xian-yong
    Zhou, Dao-bin
    Li, Jian
    LEUKEMIA RESEARCH, 2019, 81 : 19 - 24
  • [49] AL Amyloidosis - Pathogenesis and Prognosis Are Determined By the Amyloidogenic Potential of the Light Chain and the Molecular Characteristics of Malignant Plasma Cells
    Seckinger, Anja
    Hegenbart, Ute
    Beck, Susanne
    Emde, Martina
    Bochtler, Tilmann
    Kimmich, Christoph
    Muller-Tidow, Carsten
    Jauch, Anna
    Schoenland, Stefan
    Hose, Dirk
    BLOOD, 2018, 132
  • [50] Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis
    Abraham, RS
    Ballman, KV
    Dispenzieri, A
    Grill, DE
    Manske, MK
    Price-Troska, TL
    Paz, NG
    Gertz, MA
    Fonseca, R
    BLOOD, 2005, 105 (02) : 794 - 803